Cancer treatments using plasma activated liquids and elucidating the mechanisms

2016 Fiscal Year Final Research Report

• Project/Area Number: 15H05430
• Research Category: Grant-in-Aid for Young Scientists (A)
• Allocation Type: Single-year Grants
• Research Field: Plasma electronics
• Research Institution: Nagoya University
• Principal Investigator: Tanaka Hiromasa 名古屋大学, 未来社会創造機構, 特任講師 (00508129)
• Co-Investigator(Renkei-kenkyūsha): ISHIKAWA KENJI 名古屋大学, プラズマナノ工学研究センター, 特任教授 (60417384)
• Research Collaborator: NAKAMURA KAE 名古屋大学, 医学研究科, 研究員 ; KANO HIROYUKI NUエコエンジニアリング株式会社, 社長
• Project Period (FY): 2015-04-01 – 2017-03-31
• Keywords: プラズマ医療

Outline of Final Research Achievements

Recently, medical applications using non-thermal atmospheric pressure plasmas have attracted attention in the field of medicine. We have developed non-thermal atmospheric pressure plasma sources, and applied for cancer therapy. We found anti-tumor effects by plasma treated medium, which we termed “plasma-activated medium or PAM”. In this study, we further developed plasma-activated Ringer’s lactate solution or PAL, and we found that plasma-treated L-sodium lactate is an anti-tumor factor in the PAL. Based on these results, we proposed that PAL is promising as a novel chemotherapy for cancers such as peritoneally disseminated cancers.

Free Research Field

プラズマ医療